Detalhe da pesquisa
1.
Impact of Treatment Prior to Allogeneic Transplantation of Hematopoietic Stem Cells in Patients with Myelodysplastic Syndrome: Results of the Latin American Bone Marrow Transplant Registry.
Biol Blood Marrow Transplant
; 26(5): 1021-1024, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32112981
2.
Advances in the Treatment of Cardiac Amyloidosis.
Curr Treat Options Oncol
; 21(5): 36, 2020 04 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32328845
3.
Prevalence of difficult venous access and associated risk factors in highly complex hospitalised patients.
J Clin Nurs
; 26(23-24): 4267-4275, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28165645
4.
Cryopreserved versus non-cryopreserved stem cell autografts in multiple myeloma a restrospective cohort study.
Bone Marrow Transplant
; 57(8): 1313-1318, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35637267
5.
Hematological approaches to multiple myeloma: trends from a Brazilian subset of hematologists. A cross-sectional study.
Sao Paulo Med J
; 134(4): 335-41, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27557143
6.
Myelodysplastic syndromes in Latin America: state of the art.
Blood Adv
; 2(Suppl 1): 60-62, 2018 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30504205
7.
[Transfusional independence in a patient with refractory anemia with excess blasts-2 refractory to 5-azacitidine treated with deferasirox and colony stimulating factors]. / Independencia transfusional en un paciente con anemia refractaria con exceso de blastos tipo 2 refractario a 5-azacitidina tratado con deferasirox y agentes estimuladores de colonias.
Med Clin (Barc)
; 142(2): 91-2, 2014 Jan 21.
Artigo
em Espanhol
| MEDLINE | ID: mdl-23790532